What the studies show
The mechanism rests on fibroblast culture work showing that KTTKS stimulates collagen I, collagen III and fibronectin production. No human study has measured collagen synthesis in skin after topical pal-KTTKS.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
In context
Matrixyl is palmitoyl pentapeptide-4 (pal-KTTKS), a five-amino-acid fragment of type I collagen with a palmitic acid tail added so it can cross the skin barrier. Its human evidence is a 93-woman, 12-week, split-face randomised trial run by Procter & Gamble, which found significant reduction in wrinkles and fine lines against the vehicle control by both instrumental and expert-grader analysis. It is a legal cosmetic ingredient everywhere LYO covers and is not a medicine.
Matrixyl is cosmetic ingredient. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Matrixyl proven to help with collagen synthesis?
What studies are behind the grade?
Is Matrixyl approved for this?
Other outcomes for Matrixyl
- CWrinkles and fine lines (topical)1 split-face RCT (n=93, 12 wk)
- CSafety (topical)adverse1 RCT (n=93, 12 wk)
Written and maintained by LYO Research — how pages are written and checked. Reviewed 29 October 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →